MSB 2.29% $1.07 mesoblast limited

REVASCOR - CHF Insurance Coverage, page-80

  1. 194 Posts.
    lightbulb Created with Sketch. 100
    Confirmatory phase 3 trials seem to be not uncommon. Most recently PAR was advised by the FDA that they would need to have 2 phase 3 trials for their PPS drug. They approached the FDA wanting to use confirmatory data but were forced to undertake a capital raising for a confirmatory phase 3 trial that they will be running concurrently with the first phase 3 trial.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.025(2.29%)
Mkt cap ! $1.216B
Open High Low Value Volume
$1.10 $1.13 $1.05 $8.152M 7.517M

Buyers (Bids)

No. Vol. Price($)
6 69963 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.07 73154 3
View Market Depth
Last trade - 16.10pm 10/05/2024 (20 minute delay) ?
Last
$1.07
  Change
-0.025 ( 2.84 %)
Open High Low Volume
$1.09 $1.13 $1.05 1873215
Last updated 15.59pm 10/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.